BIOMAT Database Logo BIOMAT Database Logo

Acute myelofibrosis and infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. 1986

C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses
D017977 Deltaretrovirus A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE. BLV-HTLV Viruses,HTLV Viruses,HTLV-BLV Viruses,Human T-Cell Leukemia Viruses,Human T-Cell Leukemia-Lymphoma Viruses,Leukemia Viruses, Human T-Cell,T-Cell Leukemia Viruses, Human,Human T Cell Leukemia Lymphoma Viruses,Human T Cell Leukemia Viruses,Leukemia Viruses, Human T Cell,T Cell Leukemia Viruses, Human,BLV HTLV Viruses,HTLV BLV Viruses

Related Publications

C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III.
November 1985, Annals of internal medicine,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
November 1985, Annals of internal medicine,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
July 1986, Journal of immunology (Baltimore, Md. : 1950),
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
September 1985, MMWR. Morbidity and mortality weekly report,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
August 1986, MMWR. Morbidity and mortality weekly report,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
May 1985, Annals of internal medicine,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus.
August 1985, The Journal of infectious diseases,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Immunization of children infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus.
September 1986, MMWR. Morbidity and mortality weekly report,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Immunization of children infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus.
February 1987, The Pediatric infectious disease journal,
C Darne, and P Solal-Celigny, and A Herrera, and M J Ramond, and F Brun-Vezinet, and N Brousse, and P Boivin
Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor--Colorado.
June 1986, MMWR. Morbidity and mortality weekly report,
Copied contents to your clipboard!